Clay Siegall on a Busy Day

Clay is the co- founder of Seattle Genetics, Inc. It was founded in 1997 and since 2000 he has been its CEO. Dr. Clay’s close to 20 years of cancer research experience as well as therapeutic drug creation has put him ahead with other authorities in medicine and science.

From December of 1997, he served as the Executive VP of Seattle Genetics Inc. He also served as the company’s chief scientific officer until 2002. Prior to founding this company, Dr. Clay worked with Bristol-Myers Pharmaceutical Institute as a research investigator in a senior capacity from 1991 to January 1995. He was promoted to principal scientist from 1995 to December of 1997.

Clay Siegall has served as chairman at Seattle Genetics, Inc since 2004. He has been interim chairman since early 2004. At Ultrgenyx pharmaceutical, he occupies the position of director since 2014. He is the director at Washington Biotechnology and Biomedical Association (WBBA). He also sits on Fred Hutchinson Cancer Research Business Alliance board of governors. At Mirna Therapeutics, he served as a non-executive director from early 2013 to 2017.

Writing and Awards

Clay has 67 scientific papers to his credit. He has nine patent rights. He is on three scientific journals’ editorial boards. He is a member of the Cancer Treatment Research Foundation’s scientific counselor’s board. In 1995 he was awarded the Pierce Aaward for his contribution in the targeted toxins field. A few years later, in 2002, he was Ernst and Young’s Pacific Northwest Entrepreneur of the year finalist.


In one of the recent posts on Dr. Siegall’s post, the negative effects of solitary confinement are highlighted. It is argued by the author that the prisoners soon crave the touch of a fellow person and communion. They lose track of the days and nights and are not sure of the days or months any more. The negative effects of this confinement have become a cause for debate in recent years.

In another post, US military is trying to determine whether the troops who handle heavy firing machines are at risk of brain damage when they fire them. The hot gases the machines emit upon firing are a question for speculative debate.

Leave a Reply

Your email address will not be published. Required fields are marked *